China SXT Pharmaceuticals (SXTC) Long-Term Deferred Tax (2018 - 2023)
China SXT Pharmaceuticals (SXTC) posted quarterly Long-Term Deferred Tax of $652985.0 for Q3 2023, up 15.74% year-over-year from $564162.0 in Q3 2022, and up 18.12% quarter-over-quarter from $552828.0 in Q1 2023.
China SXT Pharmaceuticals (SXTC) Long-Term Deferred Tax (2018 - 2023) Analysis & Trends
China SXT Pharmaceuticals' Long-Term Deferred Tax history runs 6 years deep, the most recent figure standing at $652985.0 for Q3 2023.
- In Q3 2023, Long-Term Deferred Tax rose 15.74% year-over-year to $652985.0; the TTM figure through Sep 2023 stood at $652985.0 (up 15.74% YoY), while the FY2023 annual figure was $552828.0, up 40.99% from the prior year.
- Long-Term Deferred Tax for Q3 2023 stood at $652985.0, up from $552828.0 in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $652985.0 in Q3 2023, with the low at $12679.0 in Q3 2019.
- The 5-year median for Long-Term Deferred Tax is $321444.0 (2021), against an average of $293990.7.
- The sharpest annual moves came in 2019 and 2020: Long-Term Deferred Tax tumbled 72.74% in 2019, then surged 735.6% in 2020.
- China SXT Pharmaceuticals' Long-Term Deferred Tax stood at $12679.0 in 2019, then surged by 84.3% to $23367.0 in 2020, then soared by 1275.63% to $321444.0 in 2021, then surged by 75.51% to $564162.0 in 2022, then advanced by 15.74% to $652985.0 in 2023.
- Business Quant data shows SXTC's Long-Term Deferred Tax at $652985.0 in Q3 2023, $552828.0 in Q1 2023, and $564162.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | China SXT Pharmaceuticals | 30,840.48 | -28.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 652,985.00 |
| Mar 31, 2023 | 552,828.00 |
| Sep 30, 2022 | 564,162.00 |
| Mar 31, 2022 | 392,108.00 |
| Mar 31, 2021 | 321,444.00 |
| Sep 30, 2020 | 23,367.00 |
| Mar 31, 2020 | 112,839.00 |
| Sep 30, 2019 | 12,679.00 |
| Mar 31, 2019 | 13,504.00 |
| Sep 30, 2018 | 46,508.00 |
| Mar 31, 2018 | 6,174.00 |